Organogenesis Holdings Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Organogenesis Holdings Inc. reported Cash And Cash Equivalents At Carrying Value of $93.68 million for the year ending 2025.

  • Organogenesis Holdings Inc. showed a decrease of -30.9% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Organogenesis Holdings Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Organogenesis Holdings Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 11.0%.
  • Historical annual values: Fiscal year 2025: $93.68 million | Fiscal year 2024: $135.57 million | Fiscal year 2023: $103.84 million | Fiscal year 2022: $102.48 million | Fiscal year 2021: $113.93 million | Fiscal year 2020: $84.39 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: